Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk
European Heart Journal Open · 31.08.2024 · 4 (5)
DOI: 10.1093/ehjopen/oeae064 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 31.08.2024. Verfasst von Tarek Harb und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Med…. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCRR NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Aims
Lipoprotein(a) [Lp(a)] levels are predominantly genetically determined and repeat measurements are generally considered unlikely to be clinically useful. However, the temporal variation of Lp(a) is not well characterized. Our aim was to determine the intra-individual variability of Lp(a) and whether a repeated measure reclassified Lp(a)-specific cardiovascular risk using the European Atherosclerosis Society (EAS) consensus statement risk categories. Methods and results This retrospective cohort study analysed initial and repeated serum Lp(a) levels measured using the same methodology from 609 individuals in the Nashville Biosciences database, a de-identified electronic medical records database. Baseline and follow-up paired values were significantly different (P < 0.05), with an absolute change of ≥10 mg/dL in 38.1% [95% CI 34.2–42%] and a >25% change in 40.5% [95% CI 36.6–44.3%] of individuals. Although the categories of those whose values were in the EAS low-risk and high-risk categories did not change, 53% of those in the intermediate ‘grey-zone’ category transitioned to either the low-risk (20%) or high-risk (33%) category. Black individuals exhibited greater variability than White individuals and women exhibited greater variability than men. There was a positive correlation between the baseline Lp(a) levels and the absolute changes in Lp(a), (r = 0.59, P < 0.01).
Conclusion
Temporal-related changes in Lp(a) variability were present in many individuals. A repeat Lp(a) measure may allow more precise Lp(a)-specific cardiovascular risk prediction for individuals whose initial value is in the EAS-defined intermediate ‘grey-zone’ category. Lp(a) variability should be included in calculating the expected effect sizes in future clinical research studies targeting Lp(a).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Johns Hopkins Hospital/Halsted 500, Baltimore…
ORCID-Profile: Tarek Harb, Efthymios Ziogos, Roger S Blumenthal, Gary Gerstenblith, Thorsten M Leucker
Förderung
- NCRR NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- Clinical and Translational Science
Zitieren
APA
Harb, T., Ziogos, E., Blumenthal, R. S., Gerstenblith, G., & Leucker, T. M. (2024). Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk. European Heart Journal Open, 4(5). https://doi.org/10.1093/ehjopen/oeae064
Vancouver
Harb T, Ziogos E, Blumenthal RS, Gerstenblith G, Leucker TM. Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk. European Heart Journal Open. 2024;4(5). doi:10.1093/ehjopen/oeae064
BibTeX
@article{Harb2024,
author = {Harb, Tarek and Ziogos, Efthymios and Blumenthal, Roger S and Gerstenblith, Gary and Leucker, Thorsten M},
title = {Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk},
journal = {European Heart Journal Open},
year = {2024},
volume = {4},
number = {5},
doi = {10.1093/ehjopen/oeae064}
}
EUVIMED